:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/VE3SQNBXHRCE3MH4CJZVN4EHXI.jpg "Coronavirus in Peru: Moderna vaccine health registration canceled and Minsa Cenares Digemid COVID-19 dose withdrawn | PERU")
The Ministry of Health (Some time), through the Directorate General of Medicines, Supplies and Medicines (Tell me), ordered the nationwide recall of COVID-19 vaccines Modern Spikevax 0.20 mg/ml, which can be applied to people from six years of age onwards, i.e. adults. This occurs after the cancellation of the Conditional Sanitary Registration (RSC) of these doses.
According to Digemid portalthe RSC received the March 11, 2022 for the distribution and sale of the aforementioned vaccine by the American pharmaceutical company It is produced in various countries such as the United States, Europe and Asia.
READ MORE: They note that nearly 500,000 doses of the bivalent vaccine arrived in Peru in November
The data analyst John Carbajalwho warned of this information, specified that the document is present on the Digemid web portal through a directorial resolution of 23 December 2022, but that the reasons for the cancellation of the health register cannot be known. vaccine Modern and why a nationwide recall of the drug was also ordered.
According to Carbajal and according to data from the National Center for Strategic Health Resource Procurement (Cenares), from April 1 to December 27, 2022, 5.58 million laboratory vaccines distributed in the country Modern nationwide: Spikevax 0.20 mg/ml (adults) and Spikevax 0.10 mg/ml (6 months to 5 years).
In September 2021, the government of the former president Peter Castillo announced the signing of an agreement between Minsa and the Moderna laboratory, for the acquisition of 20 million doses of the vaccine against COVID-19.
READ ALSO: The fifth wave of COVID-19 in Peru would end in mid to late January 2023
The first arrival of COVID-19 vaccines from Modern happened the March 27, 2022 with almost 1.3 million Spikevax 0.20 mg/ml during the administration of former minister Jorge LĆ³pez.
Then, on September 21, Peru received the first batch of vaccines against COVID-19 Spikevax 0.10 mg/ml by Moderna, which can be applied from 6 months to 4 years and eleven months. It was a batch of 1.5 million of this so-called pediatric vaccine.
In this line, with respect to the type of vaccine against Moderna’s COVID-19, around 20 million subscribers were collected in 2021. They would be 8 million Spikevax 0.20 mg/ml (adults) yes 1.5 million Spikevax 0.10 mg/ml (pediatric).
At the moment only the vaccine Spikevax 0.10 mg/ml (from 6 months to 5 years) is the only one that remains with Conditional Health Registration, i.e. around 1.5 million.
Meanwhile, sources of Tell me They pointed out to this newspaper that the holder of the health register, in this case Cenares, “has the power to cancel their records”. He explained that the cancellation and collection of doses were required for what was done. Spikevax 0.10 mg/ml by Moderna.
